CKW Financial Group’s AbbVie ABBV Stock Holding History

CKW Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6K	Hold	30	–	–	﹤0.01%	115
2025 Q4	$7K	Hold	30	–	–	﹤0.01%	130
2025 Q3	$7K	Hold	30	–	–	﹤0.01%	130
2025 Q2	$6K	Hold	30	–	–	﹤0.01%	138
2025 Q1	$6K	Sell	30 -5,167	-99%	-$1M	﹤0.01%	141
2024 Q4	$924K	Hold	5,197	–	–	0.11%	24
2024 Q3	$1.02M	Hold	5,197	–	–	0.12%	23
2024 Q2	$885K	Hold	5,197	–	–	0.11%	24
2024 Q1	$939K	Hold	5,197	–	–	0.12%	26
2023 Q4	$805K	Buy	5,197 +10	+0.2%	+$1.46K	0.11%	25
2023 Q3	$773K	Hold	5,187	–	–	0.12%	25
2023 Q2	$699K	Buy	5,187 +5,167	+25,835%	+$758K	0.1%	27
2023 Q1	$3K	Buy	+20	New	+$3.06K	﹤0.01%	176
2015 Q3	–	Sell	-863	Closed	-$58K	–	151
2015 Q2	$58K	Sell	863 -319	-27%	-$20.8K	0.02%	95
2015 Q1	$67K	Buy	1,182 +154	+15%	+$9.3K	0.03%	91
2014 Q4	$67K	Hold	1,028	–	–	0.03%	83
2014 Q3	$59K	Hold	1,028	–	–	0.03%	90
2014 Q2	$59K	Buy	1,028 +811	+374%	+$42.5K	0.03%	86
2014 Q1	$55K	Sell	217 -811	-79%	-$41K	0.03%	94
2013 Q4	$54K	Buy	+1,028	New	+$50.5K	0.03%	91

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CKW Financial Group's ABBV Position: Q1 2026 in Review

CKW Financial Group held its AbbVie (ABBV) position steady in Q1 2026 at 30 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #115.

CKW Financial Group first reported a position in ABBV in Q4 2013 and has held it in 20 quarters since. The position peaked at $1.02M in Q3 2024. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

CKW Financial Group held 30 shares of AbbVie worth $6K as of Q1 2026.
CKW Financial Group left its AbbVie share count unchanged in Q1 2026.
AbbVie made up ﹤0.01% of CKW Financial Group's portfolio in Q1 2026, its #115 holding.
CKW Financial Group first reported a position in AbbVie in Q4 2013 and has held it in 20 quarters since.
CKW Financial Group's AbbVie position peaked at $1.02M in Q3 2024.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on CKW Financial Group's 13F filing for Q1 2026, filed 7 May 2026.